APDN
Income statement / Annual
Last year (2024), Applied DNA Sciences, Inc.'s total revenue was $3.43 M,
a decrease of 74.33% from the previous year.
In 2024, Applied DNA Sciences, Inc.'s net income was -$6.99 M.
See Applied DNA Sciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
09/30/2015 |
| Operating Revenue |
$3.43 M |
$13.37 M |
$18.17 M |
$9.03 M |
$1.93 M |
$5.39 M |
$3.90 M |
$4.75 M |
$4.19 M |
$9.01 M |
| Cost of Revenue |
$2.41 M
|
$7.83 M
|
$13.12 M
|
$4.10 M
|
$720.90 K
|
$877.61 K
|
$1.21 M
|
$1.08 M
|
$746.58 K
|
$384.27 K
|
| Gross Profit |
$1.02 M
|
$5.53 M
|
$5.05 M
|
$4.93 M
|
$1.21 M
|
$4.51 M
|
$2.70 M
|
$3.67 M
|
$3.44 M
|
$8.62 M
|
| Gross Profit Ratio |
0.3
|
0.41
|
0.28
|
0.55
|
0.63
|
0.84
|
0.69
|
0.77
|
0.82
|
0.96
|
| Research and Development Expenses |
$3.59 M
|
$3.74 M
|
$3.93 M
|
$3.77 M
|
$3.32 M
|
$2.97 M
|
$2.75 M
|
$2.28 M
|
$3.69 M
|
$1.64 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$11.04 M
|
$13.32 M
|
$11.24 M
|
$14.74 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$11.45 M
|
$12.75 M
|
$15.10 M
|
$12.61 M
|
$10.14 M
|
$10.28 M
|
$11.04 M
|
$13.32 M
|
$11.24 M
|
$14.74 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$844.44 K
|
$285.73 K
|
$390.42 K
|
-$37.01 K
|
-$38.39 K
|
$12.88 K
|
-$28.31 K
|
| Operating Expenses |
$15.04 M
|
$16.49 M
|
$19.02 M
|
$17.22 M
|
$13.75 M
|
$13.64 M
|
$14.34 M
|
$16.49 M
|
$15.64 M
|
$16.86 M
|
| Cost And Expenses |
$17.46 M
|
$24.32 M
|
$32.14 M
|
$21.32 M
|
$14.47 M
|
$14.51 M
|
$15.55 M
|
$17.57 M
|
$16.39 M
|
$16.86 M
|
| Interest Income |
$176.30 K
|
$75.33 K
|
$7.20 K
|
$13.68 K
|
$0.00
|
$0.00
|
$0.00
|
$2.76 K
|
$11.00 K
|
$8.41 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$115.83 K
|
$162.43 K
|
$9.62 K
|
$0.00
|
$0.00
|
$31.88 K
|
| Depreciation & Amortization |
$696.43 K
|
$1.36 M
|
$1.29 M
|
$844.44 K
|
$285.73 K
|
$390.42 K
|
$547.80 K
|
$633.33 K
|
$706.50 K
|
$490.64 K
|
| EBITDA |
-$13.33 M |
-$9.59 M |
-$12.68 M |
-$11.68 M |
-$12.25 M |
-$8.06 M |
-$11.10 M |
-$11.93 M |
-$11.49 M |
-$7.36 M |
| EBITDA Ratio |
-3.88
|
-0.72
|
-0.7
|
-1.29
|
-6.34
|
-1.5
|
-2.84
|
-2.51
|
-2.75
|
-0.82
|
| Operating Income Ratio |
-4.09
|
-0.82
|
-0.77
|
-1.36
|
-6.49
|
-1.69
|
-2.98
|
-2.7
|
-2.91
|
-0.87
|
| Total Other Income/Expenses Net |
$6.94 M
|
$930.37 K
|
$5.70 M
|
-$1.75 M
|
-$493.91 K
|
$506.83 K
|
-$46.62 K
|
-$289.60 K
|
$23.88 K
|
-$4.03 M
|
| Income Before Tax |
-$7.09 M
|
-$10.02 M
|
-$8.27 M
|
-$14.28 M
|
-$13.03 M
|
-$8.62 M
|
-$11.69 M
|
-$12.86 M
|
-$12.18 M
|
-$11.88 M
|
| Income Before Tax Ratio |
-2.07
|
-0.75
|
-0.46
|
-1.58
|
-6.75
|
-1.6
|
-3
|
-2.71
|
-2.91
|
-1.32
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$15.00 K
|
$46.62 K
|
$289.60 K
|
-$23.88 K
|
$0.00
|
| Net Income |
-$6.99 M
|
-$9.95 M
|
-$8.38 M
|
-$16.03 M
|
-$12.76 M
|
-$8.63 M
|
-$11.69 M
|
-$12.86 M
|
-$12.18 M
|
-$11.88 M
|
| Net Income Ratio |
-2.04
|
-0.74
|
-0.46
|
-1.78
|
-6.61
|
-1.6
|
-3
|
-2.71
|
-2.91
|
-1.32
|
| EPS |
-1.82 |
-15.21 |
-18.68 |
-46.35 |
-65.14 |
-187.3 |
-317.12 |
-389.88 |
-411.13 |
-501.89 |
| EPS Diluted |
-1.82 |
-15.21 |
-18.68 |
-46.35 |
-65.14 |
-187.3 |
-317.12 |
-389.88 |
-411.13 |
-501.89 |
| Weighted Average Shares Out |
$3.97 M
|
$653.77 K
|
$448.39 K
|
$345.85 K
|
$195.95 K
|
$46.09 K
|
$36.87 K
|
$32.97 K
|
$29.62 K
|
$23.67 K
|
| Weighted Average Shares Out Diluted |
$3.97 M
|
$653.77 K
|
$448.39 K
|
$345.85 K
|
$195.95 K
|
$46.09 K
|
$36.87 K
|
$32.97 K
|
$29.62 K
|
$23.67 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
